UBS Maintains Neutral on PROCEPT BioRobotics, Raises Price Target to $21

Benzinga · 2d ago
UBS analyst Patrick Wood maintains PROCEPT BioRobotics (NASDAQ:PRCT) with a Neutral and raises the price target from $20 to $21.